Tianjin Xinglian Peptide Biotechnology

Tianjin Xinglian Peptide Biotechnology

ConjuStar focuses on developing next generation innovative oncology therapies.

HQ location
Huangpu, China
Launch date
Employees
Enterprise value
$50—74m
  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor investor investor

€0.0

round
*

CNY90.0m

Seed
Total Funding000k
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads